enGene Therapeutics Inc. (ENGN) › Weighted Average Diluted SharesenGene Therapeutics Inc. (ENGN) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2022-10-31: 655.2K2023-10-31: 692.6K2024-10-31: 37.78M2025-10-31: 51.12M51.12M2022-10-31Weighted Average Diluted Shares (shares)2025-10-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-10-3151.12M+35.3%2025-12-22From 2024-11-012024-10-3137.78M+5355.1%2025-12-22From 2023-11-012023-10-31692.6K+5.7%2024-12-19From 2022-11-012022-10-31655.2K—2024-01-29From 2021-11-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)